Investors & Media

Transformative science, targeted medicines

Blueprint Medicines is a fully integrated global biopharmaceutical company that invents life-changing medicines across two strategic focus areas of allergy/inflammation and oncology/hematology. Our approach combines deep scientific expertise, modality-agnostic drug discovery capabilities, and a proven track record of R&D success. Currently, we are commercializing our approved medicine AYVAKIT/AYVAKYT® (avapritinib) in the U.S. and Europe, as well as in other regions of the world through partnerships.

SEC Filings

SEC Filings

Search
Filing date Form Description View
SC 13G

A statement of beneficial ownership of common stock by certain persons

 View HTML
0001144204-15-028799.pdf
0001144204-15-028799.rtf
0001144204-15-028799.xls
SC 13G

A statement of beneficial ownership of common stock by certain persons

 View HTML
0000921895-15-001225.pdf
0000921895-15-001225.rtf
0000921895-15-001225.xls
SC 13G

A statement of beneficial ownership of common stock by certain persons

 View HTML
0000315066-15-002589.pdf
0000315066-15-002589.rtf
4

Statement of changes in beneficial ownership of securities

 View HTML
0000315066-15-002590.pdf
0000315066-15-002590.rtf
0000315066-15-002590.xls
CT ORDER

CT ORDER

 View HTML
9999999997-15-009145.pdf
3/A

An amendment to a 3 filing. Non-EDGAR filing

 View HTML
0001104659-15-033273.pdf
0001104659-15-033273.rtf
0001104659-15-033273.xls
3

Initial filing by director officer or owner of more than ten percent.

 View HTML
0001104659-15-031949.pdf
0001104659-15-031949.rtf
0001104659-15-031949.xls
3

Initial filing by director officer or owner of more than ten percent.

 View HTML
0001104659-15-031950.pdf
0001104659-15-031950.rtf
0001104659-15-031950.xls
3

Initial filing by director officer or owner of more than ten percent.

 View HTML
0001104659-15-031956.pdf
0001104659-15-031956.rtf
0001104659-15-031956.xls
3

Initial filing by director officer or owner of more than ten percent.

 View HTML
0001104659-15-031955.pdf
0001104659-15-031955.rtf
0001104659-15-031955.xls